Do you want to read an article? Please log in or register.
Inflammatory Endotype Associated Airway Microbiome in COPD Clinical Stability and Exacerbations - A Multi-Cohort Longitudinal Analysis
Further Publications
RECOMMENDED
Related content
COMMENTED
AsthmaCOPDEmphysema
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
Lancet Respir Med.
Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R 3rd, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER8; SPIROMICS investigators
doi: 10.1016/
COMMENTED
COPD
Associations between 25-hydroxy-vitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise R, Brown TT, Drummond MB, SPIROMICS Investigators
doi: 10.1016/j.chest.2019.11.047.
RECOMMENDED
COPD
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study
Respirology.
Contoli M, Baraldo S, Conti V, Gnesini G, Marku B, Casolari P, Scrigner P, Morelli P, Saetta M, Spanevello A, Papi A
doi: 10.1111/resp.13607.
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
Lancet Respir Med.
Han MK, Quibrera PM, Carretta EE, Barr RG, Bleecker ER, Bowler RP, Cooper CB, Comellas A, Couper DJ, Curtis JL, Criner G, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Krishnan JA, Martinez CH, Pirozzi CB, O'Neal WK, Rennard S, Tashkin DP, Wedzicha JA, Woodruff P, Paine R 3rd, Martinez FJ; SPIROMICS investigators
doi: 10.1016/
COPD
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Int J Chron Obstruct Pulmon Dis.
Beeh KM, Beier J, Candler H, Wittig T
doi: 10.2147/COPD.S11765
RECOMMENDED
COPDEmphysema
Significance of FEV3/FEV6 in recognition of early airway disease in smokers at risk of development of COPD: Analysis of the SPIROMICS cohort
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Chest
Yee N, Markovic D, Buhr RG, Fortis S, Arjomandi M, Couper D, Anderson WH, Paine R 3rd, Woodruff PG, Han MK, Martinez FJ, Barr RG, Wells JM, Ortega VE, Hoffman EA, Kim V, Drummond MB, Bowler RP, Curtis JL, Cooper CB, Tashkin DP, Barjaktarevic IZ
doi: 10.1016/j.chest.2021.10.046
COMMENTED
COPDCough
The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease
Int J Chron Obstruct Pulmon Dis.
Crook S, Büsching G, Keusch S, Wieser S, Turk A, Frey M, Puhan MA, Frei A
doi: 10.2147/COPD.S156986.
RECOMMENDED
COPD
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
★ 2
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1186/s12931-020-01340-0.
RECOMMENDED
COPD
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Król A, Palmér R, Rondeau V, Rennard S, Eriksson UG, Jauhiainen A
doi: 10.1186/s12931-020-01419-8.